DEFA14A 1 tsc-4232021proxyaddlmateri.htm DEFA14A Document

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_________

SCHEDULE 14A INFORMATION
_________

Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

Filed by the Registrant ý        Filed by a Party other than the Registrant ¨
Check the appropriate box:
¨    Preliminary Proxy Statement
¨    Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
¨    Definitive Proxy Statement
ý    Definitive Additional Materials
¨    Soliciting Material Pursuant to §240.14a-12
_________

TRISTATE CAPITAL HOLDINGS, INC.
(Name of registrant as specified in its charter)

(Name of person(s) filing proxy statement if other than the registrant)
_________

Payment of Filing Fee (Check the appropriate box):
ý    No fee required.
¨    Fee computed on the table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
1)Title of each class of securities to which transaction applies:
    
2)Aggregate number of securities to which transaction applies:
    
3)Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
    
4)Proposed maximum aggregate value of transaction:
    
5)Total fee paid:
    

¨    Fee paid previously with preliminary materials.



¨    Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
1)Amount Previously Paid:
    
2)Form, Schedule or Registration Statement No:
    
3)Filing Party:
    
4)Date Filed:
    




Item 8.01 Other Events

At the TriState Capital Holdings, Inc. Annual Meeting of Shareholders on May 17, 2021, the Company’s Board of Directors recommends voting FOR Proposal 4 (“the Plan Proposal”), which seeks approval to amend the Company’s Omnibus Incentive Plan (the “Plan”) to (i) increase the number of authorized shares of common stock issuable under the Plan and (ii) clarify the persons eligible for awards under the Plan to facilitate the grant of director equity awards, other than stock options, to any person or entity with the contractual right to representation on the Board of Directors. The proposed amendment to the Plan consists of an increase to the maximum number of shares authorized for issuance under the Plan by 800,000 to 5,800,000 shares.

The Company is providing the following supplemental information to help shareholders evaluate the Plan Proposal.

The Company is providing additional clarifying information regarding the large portion of its equity allocations that have been made on a value-neutral basis in lieu of cash incentive payments that were otherwise earned for the years ended December 31, 2018 through December 31, 2020 and for the three months ended March 31, 2021. For this purpose, Figure 1 below separates cash-settled awards and stock-in-lieu of cash compensation (value neutral/value for value), which was originally reported in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020 as part of a combined figure along with grants of equity. Going forward, the Company will provide the information in Figure 1 in its proxy filings.

The Company is also affirming that as of March 31, 2021, the Company had 413,384 shares available for grant remaining in the Plan. This accounts for shares issued in 2021, predominantly in connection with the 2020 annual incentive plan settlement and related issuance of restricted shares both in lieu of cash payments, as well as other annual equity compensation grants. This remaining number of shares is significantly lower than the shares available for grant remaining as of December 31, 2020, which was prior to the Company’s annual incentive plan settlement and related issuance of restricted shares related to 2020. Ultimately, this reduced number of shares available results in a lower Shareholder Value Transfer (“SVT”) calculation, cost of plan assessment, and Burn Rate under the Plan.

As of March 31, 2021, the Company had 288,620 outstanding stock options with a weighted average exercise price of $11.00 and weighted average remaining contractual life of two months. In addition, as of March 31, 2021, the Company had 1,888,689 outstanding restricted shares which had a weighted average remaining amortization period of 2.32 years.

Figure 1 below provides the year by year Full Value Awards by specifically showing and subtracting the number of shares that were issued in lieu of cash in the applicable period, as well as the applicable Burn Rate.

Figure 1. Stock-in-Lieu of CashJan. 1, 2021 -
March 31, 2021
202020192018
Total restricted shares awarded585,386 638,832 580,453 423,113 
Less restricted stock-in-lieu of cash299,281 301,407 313,796 187,613 
Full value awards286,105 337,425 266,657 235,500 
Full value awards/total restricted shares awarded (%)48.87 %52.82 %45.94 %55.66 %
Weighted average common shares outstanding33,045,897 29,810,344 29,308,983 28,924,765 
Unadjusted burn rate0.87 %1.13 %0.91 %0.81 %
Three year average0.95 %

Using this updated current number of shares available for grant and clarified information about the portion of the equity allocation that has historically been comprised of value neutral stock-in-lieu of cash, Figure 2 below illustrates the adjustments
3


to the calculation of new + existing shares available for grant and on the calculation of net granted unexercised/unvested shares, as well as basic and full dilution.

Figure 2. Omnibus Incentive PlanShare CountBasic DilutionFull Dilution
3/31/20213/31/20213/31/2021
Shares outstanding33,160,605 
New shares requested under plan amendment800,000 2.41 %2.26 %
Existing shares available for grant413,384 1.25 %1.17 %
New + existing shares available for grant1,213,384 3.66 %3.42 %
Outstanding and unexercised stock options288,620 
Outstanding and unvested restricted shares1,888,689 
Gross granted unexercised/unvested shares2,177,309 
Less stock issued in lieu of cash (1/1/2018 - 3/31/2021)1,102,097 
Granted unexercised/unvested shares1,075,212 3.24 %3.03 %
Total share allocation2,288,596 6.90 %6.46 %
Fully diluted shares35,449,201 


4